J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers and D. M. Parkin, “GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide,” IARC Cancer Base, Vol. 10, International Agency for Research on Cancer Press, Lyon, 2010. http://globocan.iarc.fr
 P. C. M. Jansen, “Spices, Condiments and Medical Plants in Ethiopia: Their Taxonomy and Agricultural Significance,” Center for Agricultural Publishing and Documentation, Addis Ababa, 1981, pp. 76-85.
 M. F. Ramadan, “Nutritional Value, Functional Properties and Nutraceuticals Applications of Black Cumin (Nigella sativa L.): An Overview,” International Journal of Food Science & Technology, Vol. 42, No. 10, 2007, pp. 12081218. doi:10.1111/j.1365-2621.2006.01417.x
 K. E. El Tahir and D. Bakeet, “The Black Seed Nigella sativa Linnaeus—A Mine for Multi Cures: A Plea for Urgent Clinical Evaluation of Its Volatile Oil,” Review, Journal of Taibah University for Medical Sciences, Vol. 1, No. 1, 2006, pp. 1-19.
 M. Abdel-Fattah, K. Matsumoto and H. Watanabe, “AntiNociceptive Effects of Nigella sativa Oil and Its Major Components in Mice,” European Journal of Pharmacology, Vol. 400, No. 1, 2000, pp. 89-97. doi:10.1016/S0014-2999(00)00340-X
 K. E. El Tahir, M. M. Ashour and M. M. Al-Harbi, “The Cardiovascular Actions of the Volatile Oil of the Black Seed (Nigella sativa) in Rats: Elucidation of the Mechanism of Action,” General Pharmacology: The Vascular System, Vol. 24, No. 5, 1993, pp. 1123-1131. doi:10.1016/0306-3623(93)90359-6
 F. R. Dehkordi and A. F. Kamkhah, “Antihypertensive Effect of Nigella sativa Seed Extract in Patients with Mild Hypertension,” Fundamental & Clinical Pharmacology, Vol. 22, No. 4, 2008, pp. 447-452. doi:10.1111/j.1472-8206.2008.00607.x
 M. Mahfouz, R. Abdel-Maguid and M. El-Dakhakhny, “The Effect of Nigellon Therapy on the Histaminopexic Power of Blood Sera Asthmatic Patients,” Arzneimittelforschung, Vol. 15, 1965, pp. 1230-1231.
 M. H. Boskabady, N. Mohsenpoor and L. Takaloo, “Antiasthmatic Effect of Nigella sativa in Airways of Asthmatic Patients,” Phytomedicine, Vol. 17, No. 10, 2010, pp. 707-713. doi:10.1016/j.phymed.2010.01.002
 R. Medinica, S. Mukerjee, T. Huschart and W. Corbitt, “Immunomodulatory and Anticancer Activity of Nigella sativa Plant Extract in Humans,” Proceedings of the American Association for Cancer Research Annual Meeting, San Francisco, 10-13 April 1994, p. A2865.
 P. J. Houghton, R. Zarka, B. De Las Heras and J. R. Hoult, “Fixed Oil of Nigella sativa and Derived Thymoquinone Inhibit Eicosanoid Generation in Leukocytes and Membrane Lipid Peroxidation,” Planta Medica, Vol. 61, No. 1, 1995, pp. 33-36. doi:10.1055/s-2006-957994
 N. Chehl, G. Chipitsyna, Q. Gong, C. J. Yeo and H. A. Arafat, “Anti-Inflammatory Effects of the Nigella sativa Seed Extract, Thymoquinone, in Pancreatic Cancer Cells,” HPB (Oxford), Vol. 11, No. 5, 2009, pp. 373-381. doi:10.1111/j.1477-2574.2009.00059.x
 S. M. Suboh, Y. Y. Bilto and T. A. Aburjai, “Protective Effects of Selected Medicinal Plants against Protein Degradation, Lipid Peroxidation and Deformability Loss of Oxidatively Stressed Human Erythrocytes,” Phytotherapy Research, Vol. 18, No. 4, 2004, pp. 280-284. doi:10.1002/ptr.1380
 M. Burits and F. Bucar, “Antioxidant Activity of Nigella sativa Essential Oil,” Phytotherapy Research, Vol. 14, No. 5, 2000, pp. 323-328. doi:10.1002/1099-1573(200008)14:5<323::AID-PTR621>3.0.CO;2-Q
 M. F. Ramadan, L. W. Kroh and J. T. Morsel, “Radical Scavenging Activity of Black Cumin (Nigella sativa L.), Coriander (Coriandrum sativum L.), and Niger (Guizotia abyssinica Cass.) Crude Seed Oils and Oil Fractions,” Journal of Agricultural and Food Chemistry, Vol. 51, No. 24, 2003, pp. 6961-6869. doi:10.1021/jf0346713
 M. J. Salomi, S. C. Nair and K. R. Panikkar, “Inhibitory Effects of Nigella sativa and Saffron (Crocus sativus) on Chemical Carcinogenesis in Mice,” Nutrition and Cancer, Vol. 16, No. 1, 1991, pp. 67-72. doi:10.1080/01635589109514142
 N. J. Salomi, S. C. Nair, K. K. Jayawardhanan, C. D. Varghese and K. R. Panikkar, “Antitumour Principles from Nigella sativa Seeds,” Cancer Letters, Vol. 63, No. 1, 1992, pp. 41-46. doi:10.1016/0304-3835(92)90087-C
 D. R. Worthen, O. A. Ghosheh and P. A. Crooks, “The in Vitro Anti-Tumor Activity of Some Crude and Purified Components of Blackseed, Nigella sativa L.,” Anticancer research, Vol. 18, No. 3, 1998, pp. 1527-1532.
 N. El-Najjar, M. Chatila and H. Moukadem, “Reactive Oxygen Species Mediate Thymoquinone-Induced Apoptosis and Activate ERK and JNK Signaling,” Apoptosis, Vol. 15, No. 2, 2010, pp. 183-195. doi:10.1007/s10495-009-0421-z
 H. Gali-Muhtasib, D. Kuester and C. Mawrin, “Thymoquinone Triggers Inactivation of the Stress Response Pathway Sensor CHEK1 and Contributes to Apoptosis in Colorectal Cancer Cells,” Cancer Research, Vol. 68, 2008, pp. 5609-5618. doi:10.1158/0008-5472.CAN-08-0884
 M. Alhosin, A. Abusnina and M. Achour, “Induction of Apoptosis by Thymoquinone in Lymphoblastic Leukemia Jurkat Cells Is Mediated by a p73-Dependent Pathway which Targets the Epigenetic Integrator UHRF1,” Biochemical Pharmacology, Vol. 79, No. 9, 2010, pp. 12511260. doi:10.1016/j.bcp.2009.12.015
 L. R. Richards, P. Jones and J. Hughes, “The Physiological Effect of Conventional Treatment with Epigallocatechin-3-gallate, Thymoquinone, and Tannic Acid on the LNCaP Cell Line,” Biomedical Sciences Instrumentation, Vol. 42, 2006, pp. 357–362.
 L. R. Richards, P. Jones and H. Benghuzzi, “A Comparison of the Morphological Changes Associated with Conventional and Sustained Treatment with Pigallocatechin-3-gallate, Thymoquinone, and Tannic Acid on LNCaP Cells,” Biomedical Sciences Instrumentation, Vol. 44, 2008, pp. 465-470.
 S. M. K. Swamy and T. K. H. Benny, “Extraction, Isolation and Characterization of Anti-Tumor Principle, Alpha-Hederin, from the Seeds of Nigella sativa,” Planta Medica, Vol. 67, No. 1, 2001, pp. 29-32. doi:10.1055/s-2001-10628
 H. Aboul-Enein and L. Abou-Basha, “Simple HPLC Method for the Determination of Thymoquinone in Black Seed Oil (Nigella sativa Linn.),” Journal of Liquid Chromatography, Vol. 18, No. 5, 1995, pp. 895-902. doi:10.1080/10826079508010400
 R. Peto, “Epidemiology, Multistage Models, and ShortTerm Mutagenicitytests,” In: H. H. Hiatt, et al., Eds., Origins of Human Cancer, Cold Spring Harbour Laboratories, New York, 1977, pp. 1403-1438.
 V. B. Astler and F. A. Coller, “The Prognostic Significance of Direct Extension of Carcinoma of the Colon and Rectum,” Annals of Surgery, Vol. 139, No. 6, 1954, pp. 846-852. doi:10.1097/00000658-195406000-00015
 M. A. Randhawa and M. S. Alghamdi, “Anticancer Activity of Nigella sativa (Black Seed)—A Review,” The American Journal of Chinese Medicine, Vol. 39, No. 6, 2011, pp. 1075-1091. doi:10.1142/S0192415X1100941X
 S. M. Swamy and B. K. Tan, “Cytotoxic and Immunopotenciating Effects of Ethanolic Extract of Nigella sativa L. Seed,” Journal of Ethnopharmacology, Vol. 70, No. 1, 2000, pp. 1-7. doi:10.1016/S0378-8741(98)00241-4
 E. I. Salim and S. Fukushima, “Chemopreventive Potential of Volatile Oil from Black Cumin (Nigella sativa L.) Seeds against Rat Colon Carcinogenesis,” Nutrition and Cancer, Vol. 45, No. 2, 2003, pp. 195-202. doi:10.1207/S15327914NC4502_09
 S. Attoub, O. Sperandio, H. Raza and K. Arafat, “Thymoquinone as an Anticancer Agent: Evidence from Inhibition of Cancer Cells Viability and Invasion in Vitro and Tumor Growth in Vivo,” Fundamental and Clininal Pharmacology, 2012 (online). doi:10.1111/j.1472-8206.2012.01056.x
 T. Yi, S. G. Cho, Z. Yi and X. Pang, “Thymoquinone Inhibits Tumor Angiogenesis and Tumor Growth through Suppressing AKT and ERK Signaling Pathways,” Molecular Cancer Therapeutics, Vol. 7, No. 7, 2008, pp. 1789-1796. doi:10.1158/1535-7163.MCT-08-0124
 W. Asfour, S. Almadi and L. Haffar, “Thymoquinone Suppresses Cellular Proliferation, Inhibits VEGF Production and Obstructs Tumor Progression and Invasion in the Rat Model of DMH-Induced Colon Carcinogenesis,” Pharmacology & Pharmacy, Vol. 4, No. 1, 2013, pp. 7-17. doi:10.4236/pp.2013.41002
 G. M. Ganea, S. O. Fakayode and J. N. Losso, et al., “Delivery of Phytochemical Thymoquinone Using Molecular Micelle Modified Poly(D,L lactide-co-glycolide) (PLGA) Nanoparticles,” Nanotechnology, Vol. 21, No. 28, 2010, Article ID: 285104. doi:10.1088/0957-4484/21/28/285104
 A. M. Ahmed, E. M. Al-Olayan, M. A. M. Aboul-Soud and A. A. Al-Khedhairy, “The Immune Enhancer, Thymoquinone, and the Hope of Utilizing the Immune System of Aedes Caspius against Disease Agents,” African Journal of Biotechnology, Vol. 9, No. 21, 2010, pp. 31833195.
 I. O. Farah and R. A. Begum, “Effect of Nigella sativa (N. sativa L.) and Oxidative Stress on the Survival Pattern of MCF-7 Breast Cancer Cells,” Biomedical Sciences Instrumentation, Vol. 39, No. 1, 2003, pp. 359-364.
 M. A. El-Aziz, H. A. Hassan and M. H. Mohamed, et al., “The Biochemical and Morphological Alterations Following Administration of Melatonin, Retinoic Acid and Nigella sativa in Mammary Carcinoma: An Animal Model,” International Journal of Experimental Pathology, Vol. 86, No. 6, 2005, pp. 383-396. doi:10.1111/j.0959-9673.2005.00448.x
 S. R. Samarakoon, P. B. Thabrew, D. Galhena, De-Silva and K. H. Tennekoon, “A Comparison of the Cytotoxic Potential of Standardized Aqueous and Ethanolic Extracts of a Polyherbal Mixture Comprised of Nigella sativa (Seeds), Hemidesmus Indicus (Roots) and Smilax Glabra (Rhizome),” Pharmacognosy Research, Vol. 2, No. 6, 2010, pp. 335-342. doi:10.4103/0974-8490.75451
 S. Rooney and M. F. Ryan, “Modes of Action of Alpha-Hederin and Thymoquinone, Active Constituents of Nigella sativa, against HEP-2 Cancer Cells,” Anticancer Research, Vol. 25, No. 6B, 2005, pp. 4255-4259